Compusense Oegstgeest   Report issue

For profit Phase 4
Founded: Oegstgeest Netherlands (1993)
Status: No NME R&D (1993)

Organization Overview

First Clinical Trial
2006
NCT00986050
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Alternative names

Compusense Oegstgeest ( electronic randomization and CRF)

Active Ingredients

Drugs in Phase 4 Trials (2)

abciximab (Reopro) (1 trial)

sirolimus (rapamune) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infarction (Phase 4)

Myocardial Infarction (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2